載入...
Clinical Investigation of Receptor and Non-Receptor Tyrosine Kinase Inhibitors for the Treatment of Epithelial Ovarian Cancer
INTRODUCTION: Epithelial ovarian cancer (EOC) is the second most common gynecologic malignancy and the leading cause of death from gynecologic cancer in the United States. EOC is an exquisitely chemo-sensitive disease with response rates of over 75% in the upfront setting. Despite this, due to high...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4103698/ https://ncbi.nlm.nih.gov/pubmed/23937415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2013.826650 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|